Cargando…
BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells
Loss of 53BP1 rescues BRCA1 deficiency and is associated with BRCA1-deficient and triple-negative breast cancers (TNBC) and with resistance to genotoxic drugs. The mechanisms responsible for decreased 53BP1 transcript and protein levels in tumors remain unknown. Here, we demonstrate that BRCA1 loss...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549967/ https://www.ncbi.nlm.nih.gov/pubmed/23337117 http://dx.doi.org/10.1083/jcb.201204053 |
_version_ | 1782256510165843968 |
---|---|
author | Grotsky, David A. Gonzalez-Suarez, Ignacio Novell, Anna Neumann, Martin A. Yaddanapudi, Sree C. Croke, Monica Martinez-Alonso, Montserrat Redwood, Abena B. Ortega-Martinez, Sylvia Feng, Zhihui Lerma, Enrique Ramon y Cajal, Teresa Zhang, Junran Matias-Guiu, Xavier Dusso, Adriana Gonzalo, Susana |
author_facet | Grotsky, David A. Gonzalez-Suarez, Ignacio Novell, Anna Neumann, Martin A. Yaddanapudi, Sree C. Croke, Monica Martinez-Alonso, Montserrat Redwood, Abena B. Ortega-Martinez, Sylvia Feng, Zhihui Lerma, Enrique Ramon y Cajal, Teresa Zhang, Junran Matias-Guiu, Xavier Dusso, Adriana Gonzalo, Susana |
author_sort | Grotsky, David A. |
collection | PubMed |
description | Loss of 53BP1 rescues BRCA1 deficiency and is associated with BRCA1-deficient and triple-negative breast cancers (TNBC) and with resistance to genotoxic drugs. The mechanisms responsible for decreased 53BP1 transcript and protein levels in tumors remain unknown. Here, we demonstrate that BRCA1 loss activates cathepsin L (CTSL)–mediated degradation of 53BP1. Activation of this pathway rescued homologous recombination repair and allowed BRCA1-deficient cells to bypass growth arrest. Importantly, depletion or inhibition of CTSL with vitamin D or specific inhibitors stabilized 53BP1 and increased genomic instability in response to radiation and poly(adenosine diphosphate–ribose) polymerase inhibitors, compromising proliferation. Analysis of human breast tumors identified nuclear CTSL as a positive biomarker for TNBC, which correlated inversely with 53BP1. Importantly, nuclear levels of CTSL, vitamin D receptor, and 53BP1 emerged as a novel triple biomarker signature for stratification of patients with BRCA1-mutated tumors and TNBC, with potential predictive value for drug response. We identify here a novel pathway with prospective relevance for diagnosis and customization of breast cancer therapy. |
format | Online Article Text |
id | pubmed-3549967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-35499672013-07-21 BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells Grotsky, David A. Gonzalez-Suarez, Ignacio Novell, Anna Neumann, Martin A. Yaddanapudi, Sree C. Croke, Monica Martinez-Alonso, Montserrat Redwood, Abena B. Ortega-Martinez, Sylvia Feng, Zhihui Lerma, Enrique Ramon y Cajal, Teresa Zhang, Junran Matias-Guiu, Xavier Dusso, Adriana Gonzalo, Susana J Cell Biol Research Articles Loss of 53BP1 rescues BRCA1 deficiency and is associated with BRCA1-deficient and triple-negative breast cancers (TNBC) and with resistance to genotoxic drugs. The mechanisms responsible for decreased 53BP1 transcript and protein levels in tumors remain unknown. Here, we demonstrate that BRCA1 loss activates cathepsin L (CTSL)–mediated degradation of 53BP1. Activation of this pathway rescued homologous recombination repair and allowed BRCA1-deficient cells to bypass growth arrest. Importantly, depletion or inhibition of CTSL with vitamin D or specific inhibitors stabilized 53BP1 and increased genomic instability in response to radiation and poly(adenosine diphosphate–ribose) polymerase inhibitors, compromising proliferation. Analysis of human breast tumors identified nuclear CTSL as a positive biomarker for TNBC, which correlated inversely with 53BP1. Importantly, nuclear levels of CTSL, vitamin D receptor, and 53BP1 emerged as a novel triple biomarker signature for stratification of patients with BRCA1-mutated tumors and TNBC, with potential predictive value for drug response. We identify here a novel pathway with prospective relevance for diagnosis and customization of breast cancer therapy. The Rockefeller University Press 2013-01-21 /pmc/articles/PMC3549967/ /pubmed/23337117 http://dx.doi.org/10.1083/jcb.201204053 Text en © 2013 Grotsky et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/). |
spellingShingle | Research Articles Grotsky, David A. Gonzalez-Suarez, Ignacio Novell, Anna Neumann, Martin A. Yaddanapudi, Sree C. Croke, Monica Martinez-Alonso, Montserrat Redwood, Abena B. Ortega-Martinez, Sylvia Feng, Zhihui Lerma, Enrique Ramon y Cajal, Teresa Zhang, Junran Matias-Guiu, Xavier Dusso, Adriana Gonzalo, Susana BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells |
title | BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells |
title_full | BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells |
title_fullStr | BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells |
title_full_unstemmed | BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells |
title_short | BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells |
title_sort | brca1 loss activates cathepsin l–mediated degradation of 53bp1 in breast cancer cells |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549967/ https://www.ncbi.nlm.nih.gov/pubmed/23337117 http://dx.doi.org/10.1083/jcb.201204053 |
work_keys_str_mv | AT grotskydavida brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT gonzalezsuarezignacio brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT novellanna brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT neumannmartina brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT yaddanapudisreec brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT crokemonica brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT martinezalonsomontserrat brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT redwoodabenab brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT ortegamartinezsylvia brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT fengzhihui brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT lermaenrique brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT ramonycajalteresa brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT zhangjunran brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT matiasguiuxavier brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT dussoadriana brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells AT gonzalosusana brca1lossactivatescathepsinlmediateddegradationof53bp1inbreastcancercells |